MGI Pharma's P2P Acquisition

MGI Pharma raised a round of funding on December 11, 2007. Investors include Eisai Corporation.

MGI Pharma is an oncology-focused biopharmaceutical company that acquires, develops and commercializes proprietary products that address the unmet needs of cancer patients. MGI Pharma has a portfolio …

Articles about MGI Pharma's P2P Acquisition: